Michael Rapp, Director at Immunome Inc. (IMNM), bought 104,696 shares at $18.38 ($1.9M) on 2021-05-24, disclosed to the SEC on 2021-05-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.38 | 31,895 | $586K | 30.5% |
| 2 | $18.38 | 31,895 | $586K | 30.5% |
| 3 | $18.32 | 19,303 | $354K | 18.4% |
| 4 | $18.32 | 19,303 | $354K | 18.4% |
| 5 | $18.94 | 2,300 | $44K | 2.3% |
| Total | $18.37 avg | 104,696 |
| $1.9M |
| 100% |
| Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-31 | $123K | — | Filing → |
| ZYNE | BUY | 2018-05-02 | $157K | — | Filing → |